Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Absalon D. Gutierrez
The Use of SGLT-2 Inhibitors in Type 2 Diabetes and Heart Failure
Metabolic Syndrome and Related Disorders
Internal Medicine
Endocrinology
Metabolism
Diabetes
Related publications
SGLT-2 Inhibitors and Their Potential in the Treatment of Diabetes
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal Medicine
Pharmacology
Heart Failure and Type 2 Diabetes: From CVOTs, With Hope
Diabetes, Obesity and Metabolism
Internal Medicine
Endocrinology
Metabolism
Diabetes
Heart Failure: A Preventable and Treatable Complication of Type 2 Diabetes
Journal of Diabetes
Endocrinology
Metabolism
Diabetes
Effects of Sodium Glucose Cotransporter Type 2 Inhibitors on Heart Failure
Diabetes, Obesity and Metabolism
Internal Medicine
Endocrinology
Metabolism
Diabetes
TNF Receptor 1/2 Predict Heart Failure Risk in Type 2 Diabetes Mellitus Patients
International Heart Journal
Medicine
Cardiovascular Medicine
Cardiology
The Adverse Impact of Type 2 Diabetes on Brain Volume in Heart Failure
Journal of Clinical and Experimental Neuropsychology
Clinical Psychology
Neurology
Ertugliflozin: A Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitor for Glycemic Control in Type 2 Diabetes
Therapeutics and Clinical Risk Management
Use of DPP-4 Inhibitors in Type 2 Diabetes: Focus on Sitagliptin
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal Medicine
Pharmacology
SGLT-2 Inhibitors – Are They to Stay?
Diabesity